首页> 美国卫生研究院文献>other >A Review of Demographic Medical and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood
【2h】

A Review of Demographic Medical and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood

机译:儿童时期造血干细胞(HSCT)和骨髓移植(BMT)幸存者中与健康相关生活质量(HRQOL)相关的人口统计学医学和治疗变量的综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hematopoietic stem cell transplantation (HSCT) is a standard treatment after disease relapse and failure of conventional treatments for cancer in childhood or as a first line treatment for some high-risk cancers. Since hematopoietic stem cells can be found in the marrow (previously called a bone marrow transplantation) or periphery, we refer to HSCT as inclusive of HSCT regardless of the origin of the stem cells. HSCT is associated with adverse side effects, prolonged hospitalization, and isolation. Previous studies have shown that survivors of HSCT are at particularly high risk for developing late effects and medical complications, and thus, in addition to survival, quality of life in survivors of HSCT is an important outcome. This review summarizes and distills findings on the health-related quality of life (HRQOL) of long-term childhood cancer survivors of HSCT and examines significant sociodemographic, medical, disease and treatment correlates of HRQOL, as well as the methodology of the studies (instruments, type of studies, timing of assessment, type of transplantation). Because previous reviews covered the studies published before 2006, this review searched three databases published between January, 2006, and August, 2016. The search identified nine studies, including 2 prospective cohort studies and 7 cross-sectional studies. All studies reported a follow-up time of >5 years. The review found that HRQOL is significantly impacted over time following childhood HSCT, with salient correlates of HRQOL found to be presence of a severe chronic health or major medical condition, graft vs. host disease (GVHD), or pain. Continual evaluation of HRQOL must be integrated into long-term follow-up after childhood HSCT, and intervention should be offered for those survivors with poor HRQOL. Longitudinal studies should be emphasized in future research to allow for predictor models of resilience and poor HRQOL.
机译:造血干细胞移植(HSCT)是疾病复发和常规治疗失败后的标准治疗方法,是儿童期的常规治疗方法,还是某些高危癌症的一线治疗方法。由于造血干细胞可以在骨髓(以前称为骨髓移植)或周围发现,因此无论干细胞的来源如何,我们都将HSCT包括在内。 HSCT与不良副作用,长期住院和隔离有关。先前的研究表明,HSCT的幸存者发生晚期疾病和医疗并发症的风险特别高,因此,除了生存之外,HSCT的幸存者的生活质量是重要的结果。这篇综述总结并提炼了HSCT长期儿童癌症幸存者与健康相关的生活质量(HRQOL)的发现,并研究了HRQOL在社会人口统计学,医学,疾病和治疗方面的重要关联,以及研究方法(仪器)。 ,研究类型,评估时机,移植类型)。由于以前的评论涵盖了2006年之前发表的研究,因此该评论搜索了2006年1月至2016年8月之间发表的三个数据库。该搜索确定了9项研究,包括2项前瞻性队列研究和7项横断面研究。所有研究报告随访时间均大于5年。该审查发现,HRQOL在儿童期HSCT之后随时间受到显着影响,HRQOL的显着相关性被发现为存在严重的慢性健康或重大疾病,移植物抗宿主病(GVHD)或疼痛。在儿童期HSCT之后,必须将对HRQOL的持续评估纳入长期随访中,并对那些HRQOL较差的幸存者进行干预。在未来的研究中应强调纵向研究,以建立适应力和HRQOL较差的预测模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号